https://pubmed.ncbi.nlm.nih.gov/24933606/
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma
BRAF and MEK inhibitors are not established treatments for non-V600 mutation-positive metastatic melanoma. We carried out a retrospective analysis of efficacy...